5A9U:
reference: Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F., Shaw AT, Friboulet L, Leshchiner I, Gainor JF, Bergqvist S, Brooun A, Burke BJ, Deng YL, Liu W, Dardaei L, Frias RL, Schultz KR, Logan J, James LP, Smeal T, Timofeevski S, Katayama R, Iafrate AJ, Le L, McTigue M, Getz G, Johnson TW, Engelman JA, N Engl J Med. 2016 Jan 7;374(1):54-61. doi: 10.1056/NEJMoa1508887. Epub 2015 Dec , 23. PMID: 26698910

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).